Global Multilayer Co-extruded Film Infusion Bags Market Strategic Research Report

Scope of the Report

Multilayer co-extruded film infusion bags are packaging containers for infusions. They are made by co-extruding different high-performance polymer materials into a structure usually consisting of 3 or 5 layers. The inner layer is in contact with the medicinal liquid and is made of medical-grade polyolefin materials. The barrier layer can prevent the entry of oxygen and water vapor. The reinforcing layer improves mechanical strength, and the outer layer has good wear - resistance and printability. These bags have excellent properties such as good barrier performance, high chemical stability, and excellent mechanical properties, ensuring the safety and stability of the medicinal liquid. This report only counts empty infusion bags that do not contain pharmaceutical liquids.

The global market for multilayer co-extruded film infusion bags is being driven primarily by the rising demand for non-PVC, biocompatible, and environmentally safer alternatives to traditional PVC-based infusion systems. These advanced film materials, often composed of polyolefin (PP/PE), EVOH, or other thermoplastics, offer excellent chemical resistance, thermal stability, and transparency, which make them ideal for a variety of intravenous (IV) therapies. Growing awareness of the potential health risks associated with DEHP-plasticized PVC bags—especially their leaching of phthalates—has prompted stringent regulatory action in regions like the EU, China, and the United States. Additionally, as the global population ages and chronic disease incidence rises, hospitals and healthcare providers are increasing their usage of infusion therapies, thus expanding the demand for reliable, lightweight, and durable infusion packaging. Pharmaceutical companies are also benefiting from the longer shelf life and reduced contamination risks that multilayer co-extruded films provide, especially for sensitive drug formulations and parenteral nutrition.

Despite the clear advantages, the multilayer co-extruded film infusion bag market faces several challenges that could hamper its growth. One major barrier is the relatively high production cost associated with advanced multilayer films, due to the complexity of co-extrusion processes and the need for specialized raw materials like EVOH and cyclic olefin polymers (COP). This makes non-PVC infusion bags more expensive than their traditional counterparts, limiting adoption in cost-sensitive markets or public healthcare systems with tight budgets. Another challenge lies in compatibility and regulatory hurdles—different drug formulations may interact differently with multilayer films, requiring exhaustive stability testing and regulatory approvals, which increase time-to-market for drug manufacturers. Furthermore, the manufacturing infrastructure and equipment needed for producing and filling these bags are not universally standardized, leading to potential bottlenecks for new entrants. These factors, combined with strong competition from established PVC-based bag manufacturers, pose a constraint on faster market penetration.

This report presents a comprehensive overview of the global Multilayer Co-extruded Film Infusion Bags market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Single Chamber Infusion Bag
• Dual Chamber Infusion Bag
• Other

Segment by Capacity

• 250ml
• 100ml
• 50ml
• 500ml
• Other

Segment by Application

• Hospital
• Clinic
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Multilayer Co-extruded Film Infusion Bags market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospital, Clinic, Other evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact